Mc. Chen et al., Overexpression of Bcl-2 enhances LIGHT- and interferon-gamma-mediated apoptosis in Hep3BT2 cells, J BIOL CHEM, 275(49), 2000, pp. 38794-38801
LIGHT is a member of the tumor necrosis factor superfamily and is the Ligan
d for LT-betaR, HVEM, and decoy receptor 3. LIGHT has a cytotoxic effect, w
hich is further enhanced by the presence of interferon-gamma (IFN-gamma). A
lthough LIGHT/IFN-gamma can activate caspase activity, neither benzyloxycar
bonyl-Asp-Glu-Val-Asp-fluoromethylketone nor benzyloxycarbonyl-Val-Ala-Asp-
fluoromethylketone can completely inhibit LIGHT/IFN-gamma -mediated apoptos
is. Moreover, overexpression of Bcl-2 further enhances LIGHT/IFN-gamma -med
iated apoptosis. It appears that LIGHT and IFN-gamma act synergistically to
activate caspase-3, with the resultant cleavage of Bcl-2, removal of the B
H4 domain, leading to conversion of Bcl-2 from an antiapoptotic to a proapo
ptotic form in p53-deficient hepatocellular carcinoma Hep3BT2 cells. Thus,
LIGHT seems to be able to override the protective effect of Bcl-2 and induc
e cell death. Although benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethylketone
and benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone can prevent the cleav
age of Bcl-2 by LIGHT/IFN-gamma they only partially inhibit apoptosis in He
p3BT2 cells that are overexpressing Bcl-2. In contrast, both LIGHT/IFN-gamm
a -mediated apoptosis and Bcl-2 cleavage are inhibited by free radical scav
engers, indicating that free radicals may play an essential role in LIGHT/I
FN-gamma -mediated apoptosis at a step upstream of caspase-3 activation. Th
ese results suggest that LIGHT signaling may diverge into multiple, separat
e processes.